ENZ News and Press, Enzo Biochem Inc.

2025-03-28 16:24:46 ET Read the full article on Seeking Alpha For further details see: Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall

FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quot...

2025-03-17 16:46:15 ET More on Enzo Biochem Enzo Biochem receives NYSE non-compliance notice Financial information for Enzo Biochem Read the full article on Seeking Alpha For further details see: Enzo Biochem Non-GAAP EPS of -$0.02, revenue of $7.3M

FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross margin and opera...

Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...

2025-01-22 09:30:00 ET Summary Kingdom Capital Advisors (KCA Value Composite) returned 2.07% (net of fees) in the fourth quarter, vs. 0.33% for the Russell 2000 TR, 2.41% for the S&P 500 TR, and 4.93% for the NASDAQ 100 TR. Our top contributors to Q4 returns were United Natura...

2025-01-14 16:24:37 ET More on Enzo Biochem Dividend scorecard for Enzo Biochem Financial information for Enzo Biochem Read the full article on Seeking Alpha For further details see: Enzo Biochem receives NYSE non-compliance notice

FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01B and Section 802...